CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,055 Cr | ₹1,200 Cr | ₹1,017 Cr | ₹853 Cr | ₹713 Cr |
What is the latest Revenue of CONCORD BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,055 Cr |
| Mar2025 | ₹1,200 Cr |
| Mar2024 | ₹1,017 Cr |
| Mar2023 | ₹853 Cr |
| Mar2022 | ₹713 Cr |
How is Revenue of CONCORD BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,055 Cr | -12.10 | |
| Mar2025 | ₹1,200 Cr | 18.01 | |
| Mar2024 | ₹1,017 Cr | 19.20 | |
| Mar2023 | ₹853 Cr | 19.67 | |
| Mar2022 | ₹713 Cr | - | |
Compare Revenue of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,961.5 Cr | -0.3% | 8.7% | -21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -0.3% |
8.7% |
-21.4% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses